Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (AEGEAN)
2023
9 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
2.08
OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (AEGEAN) | Researchclopedia
·
Tianjin Medical University Cancer Institute and Hospital
Guang Li
·
Kunming Medical University
D. Van Luong
·
Hanoi Lung Hospital
Somchareon Saeteng
·
Chiang Mai University
F. Tanaka
·
University of Occupational and Environmental Health Japan
Gregory Kulesza
·
Manipal Hospital
Stefan Watzka
·
Polyclinic General Hospital
László Urbán
·
Emam Reza Hospital
Zsuzsanna Szalai
·
Petz Aladár Megyei Oktató Kórház
H. Akamatsu
·
Wakayama Medical University
Jin‐Hyoung Kang
·
The Catholic University of Korea Seoul St. Mary's Hospital
Francesco Orlandi
·
Instituto Profesional Providencia
Guzel Mukhametshina
·
Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Andreas Pircher
·
Universität Innsbruck
Carlos Henrique Andrade Teixeira
·
Hospital Alemão Oswaldo Cruz
Mike Aperghis
·
GeneCare Research Institute (Japan)
Gary J. Doherty
·
GeneCare Research Institute (Japan)
R. Doake
·
GeneCare Research Institute (Japan)
Tamer M. Fouad
·
New York School of Regional Anesthesia
David Harpole
·
Duke University